Volume | 263,162 |
|
|||||
News | (2) | ||||||
Day High | 1.50 | Low High |
|||||
Day Low | 1.31 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Enlivex Therapeutics Ltd | ENLV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.47 | 1.31 | 1.50 | 1.38 | 1.40 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,190 | 263,162 | $ 1.37 | $ 360,118 | - | 1.15 - 4.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:03 | 4,636 | $ 1.38 | USD |
Enlivex Therapeutics Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
25.05M | 18.42M | - | 0 | -29.07M | -1.58 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Enlivex Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENLV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.44 | 1.50 | 1.30 | 1.44 | 33,795 | -0.06 | -4.17% |
1 Month | 1.65 | 1.76 | 1.30 | 1.54 | 60,603 | -0.27 | -16.36% |
3 Months | 3.37 | 4.59 | 1.15 | 2.28 | 182,413 | -1.99 | -59.05% |
6 Months | 1.86 | 4.59 | 1.15 | 2.49 | 136,504 | -0.48 | -25.81% |
1 Year | 2.65 | 4.59 | 1.15 | 2.42 | 81,621 | -1.27 | -47.92% |
3 Years | 9.29 | 13.95 | 1.15 | 6.51 | 85,539 | -7.91 | -85.15% |
5 Years | 11.20 | 44.90 | 1.15 | 9.79 | 163,368 | -9.82 | -87.68% |
Enlivex Therapeutics Description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. |